These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 31305133)

  • 1. Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome.
    Chen Z; Ou H; Wu H; Wu P; Mo Z
    DNA Cell Biol; 2019 Aug; 38(8):754-762. PubMed ID: 31305133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
    Sørensen AE; Udesen PB; Wissing ML; Englund ALM; Dalgaard LT
    Chem Biol Interact; 2016 Nov; 259(Pt A):8-16. PubMed ID: 27270454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review.
    Abdalla M; Deshmukh H; Atkin SL; Sathyapalan T
    Life Sci; 2020 Oct; 259():118174. PubMed ID: 32745529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of MiRNA in polycystic ovary syndrome (PCOS).
    Chen B; Xu P; Wang J; Zhang C
    Gene; 2019 Jul; 706():91-96. PubMed ID: 31054362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome.
    Xue Y; Lv J; Xu P; Gu L; Cao J; Xu L; Xue K; Li Q
    J Cell Biochem; 2018 May; 119(5):3913-3921. PubMed ID: 29193229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
    Lin L; Du T; Huang J; Huang LL; Yang DZ
    Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and insulin--two key players in polycystic ovary syndrome. Recent concepts in the pathophysiology and genetics of polycystic ovary syndrome.
    Schuring AN; Schulte N; Sonntag B; Kiesel L
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):9-15. PubMed ID: 18209494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiRNAs expression profiling of rat ovaries displaying PCOS with insulin resistance.
    Zhang C; Yu C; Lin Z; Pan H; Li K; Ma H
    Arch Gynecol Obstet; 2020 Nov; 302(5):1205-1213. PubMed ID: 32757043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
    Xu B; Zhang YW; Tong XH; Liu YS
    Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-targeted profiling of circulating microRNAs in women with polycystic ovary syndrome (PCOS): effects of obesity and sex hormones.
    Murri M; Insenser M; Fernández-Durán E; San-Millán JL; Luque-Ramírez M; Escobar-Morreale HF
    Metabolism; 2018 Sep; 86():49-60. PubMed ID: 29410349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of miRNAs in polycystic ovary syndrome with insulin resistance.
    Luo Y; Cui C; Han X; Wang Q; Zhang C
    J Assist Reprod Genet; 2021 Feb; 38(2):289-304. PubMed ID: 33405004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of miRNA - 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome.
    Rashad NM; Ateya MA; Saraya YS; Elnagar WM; Helal KF; Lashin ME; Abdelrhman AA; Alil AE; Yousef MS
    J Ovarian Res; 2019 May; 12(1):39. PubMed ID: 31064393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Dysfunction in Polycystic Ovary Syndrome.
    Zeng X; Huang Q; Long SL; Zhong Q; Mo Z
    DNA Cell Biol; 2020 Aug; 39(8):1401-1409. PubMed ID: 32077751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNAs as a piece of polycystic ovary syndrome puzzle.
    Abolghasemi M; Mahjoub S
    Mol Biol Rep; 2021 Apr; 48(4):3845-3851. PubMed ID: 33993404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review.
    Nasser JS; Altahoo N; Almosawi S; Alhermi A; Butler AE
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of several circulating microRNAs from a genome-wide circulating microRNA expression profile as potential biomarkers for impaired glucose metabolism in polycystic ovarian syndrome.
    Jiang L; Huang J; Chen Y; Yang Y; Li R; Li Y; Chen X; Yang D
    Endocrine; 2016 Jul; 53(1):280-90. PubMed ID: 26860517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Species in Follicular Fluid Associating With Polycystic Ovary Syndrome and Related Intermediary Phenotypes.
    Sørensen AE; Wissing ML; Englund AL; Dalgaard LT
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1579-89. PubMed ID: 26771704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review.
    Carvalho LML; Dos Reis FM; Candido AL; Nunes FFC; Ferreira CN; Gomes KB
    Endocr Regul; 2018 Oct; 52(4):208-221. PubMed ID: 31517612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
    Siddiqui S; Mateen S; Ahmad R; Moin S
    J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.